Michael Gladstone

Michael Gladstone is a Partner at Atlas Venture, where he builds and invests in innovative therapeutics companies. He earned a BA in biochemical sciences from Harvard College and has been instrumental in the founding and development of numerous biotech firms, including Akero Therapeutics, Day One Biopharmaceuticals, and Third Harmonic Bio.

He is passionate about working alongside world-class entrepreneurs to translate scientific discoveries into new medicines for patients. Michael has a keen interest in cultivating the next generation of biotech leaders and has expressed a strong belief in empowering young talent within the industry.

Before his venture career, Michael conducted HIV vaccine research at Beth Israel Deaconess Medical Center.